164 related articles for article (PubMed ID: 37449879)
1. Antibiotic dispensing during first year of COVID-19 pandemic in Brazilian public hospitals.
Pereira ML; Mothé DA; Pinheiro KS; Gonçalves SS; Santos KV
Future Microbiol; 2023 Jul; 18():639-647. PubMed ID: 37449879
[No Abstract] [Full Text] [Related]
2. Increase in veterinary prescriptions of azithromycin during the COVID-19 pandemic in Brazil.
Del Fiol FS; Bergamaschi CC; De Andrade-Jr IP; Tolentino da Silva M; Barberato-Filho S; Bellini Silva BG; Higa Nakaghi AC; Cruz Lopes L
J Infect Dev Ctries; 2023 Jul; 17(7):930-936. PubMed ID: 37515794
[TBL] [Abstract][Full Text] [Related]
3. Immediate and long-term effects of COVID-19 on antibiotic dispensing: increasing use of Watch antibiotics.
Tomic T; Henman M; Tadic I; Antic Stankovic J; Santric Milicevic M; Bukumiric Z; Lakic D; Odalovic M
J Infect Dev Ctries; 2024 Apr; 18(4):504-512. PubMed ID: 38728639
[TBL] [Abstract][Full Text] [Related]
4. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
[TBL] [Abstract][Full Text] [Related]
5. Prescribing of Outpatient Antibiotics Commonly Used for Respiratory Infections Among Adults Before and During the Coronavirus Disease 2019 Pandemic in Brazil.
Solanky D; McGovern OL; Edwards JR; Mahon G; Patel TS; Lessa FC; Hicks LA; Patel PK
Clin Infect Dis; 2023 Jul; 77(Suppl 1):S12-S19. PubMed ID: 37406052
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use.
Olesen SW; Torrone EA; Papp JR; Kirkcaldy RD; Lipsitch M; Grad YH
J Infect Dis; 2019 Jan; 219(4):619-623. PubMed ID: 30239814
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
[TBL] [Abstract][Full Text] [Related]
8. Increased antimicrobial resistance against azithromycin during COVID: role of irrational utilization.
Tanwir S; Sabah A; Khatoon A; Afridi FI
J Pak Med Assoc; 2024 Feb; 74(2):258-271. PubMed ID: 38419222
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.
Bissessor M; Tabrizi SN; Twin J; Abdo H; Fairley CK; Chen MY; Vodstrcil LA; Jensen JS; Hocking JS; Garland SM; Bradshaw CS
Clin Infect Dis; 2015 Apr; 60(8):1228-36. PubMed ID: 25537875
[TBL] [Abstract][Full Text] [Related]
10. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Long-Term Macrolide Exposure on the Oropharyngeal Microbiome and Macrolide Resistance in Healthy Adults and Consequences for Onward Transmission of Resistance.
Burr LD; Taylor SL; Richard A; Schreiber V; Lingman S; Martin M; Papanicolas LE; Choo JM; Rogers GB
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0224621. PubMed ID: 35293783
[TBL] [Abstract][Full Text] [Related]
12. Macrolide antibiotics for bronchiectasis.
Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980
[TBL] [Abstract][Full Text] [Related]
13. A pandemic within a pandemic? Admission to COVID-19 wards in hospitals is associated with increased prevalence of antimicrobial resistance in two African settings.
Elton L; Abdel Hamid MM; Tembo J; Elbadawi H; Maluzi K; Abdelraheem MH; Cullip T; Kabanda C; Roulston K; Honeyborne I; Thomason MJ; Elhag K; Mohammed A; Adam A; Mulonga K; Sikakena K; Matibula P; Kabaso M; Nakazwe R; Fwoloshi S; Zumla A; McHugh TD
Ann Clin Microbiol Antimicrob; 2023 Apr; 22(1):25. PubMed ID: 37055793
[TBL] [Abstract][Full Text] [Related]
14. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.
Malhotra-Kumar S; Lammens C; Coenen S; Van Herck K; Goossens H
Lancet; 2007 Feb; 369(9560):482-90. PubMed ID: 17292768
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic misuse and compliance with infection control measures during COVID-19 pandemic in community pharmacies in Egypt.
Elsayed AA; Darwish SF; Zewail MB; Mohammed M; Saeed H; Rabea H
Int J Clin Pract; 2021 Jun; 75(6):e14081. PubMed ID: 33559255
[TBL] [Abstract][Full Text] [Related]
16. Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.
Seidman JC; Coles CL; Silbergeld EK; Levens J; Mkocha H; Johnson LB; Muñoz B; West SK
Int J Epidemiol; 2014 Aug; 43(4):1105-13. PubMed ID: 24659584
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance profile of common uropathogens during COVID-19 pandemic: hospital based epidemiologic study.
Abdel Gawad AM; Ashry WMO; El-Ghannam S; Hussein M; Yousef A
BMC Microbiol; 2023 Jan; 23(1):28. PubMed ID: 36694128
[TBL] [Abstract][Full Text] [Related]
18. Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.
Smith DRM; Shirreff G; Temime L; Opatowski L
PLoS Med; 2023 Jun; 20(6):e1004240. PubMed ID: 37276186
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic consumption in developing countries defies global commitments: an overview on Brazilian growth in consumption.
Neves E Castro PB; da Silva Rodrigues DA; Roeser HMP; da Fonseca Santiago A; de Cássia Franco Afonso RJ
Environ Sci Pollut Res Int; 2020 Jun; 27(17):21013-21020. PubMed ID: 32266618
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
